Share This Author
Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- M. Sandström, Ulrike Garske-Román, M. Lubberink
- Medicine, PhysicsThe Journal of Nuclear Medicine
- 1 January 2013
A method based on repeated whole-body imaging in combination with blood and urinary activity data over time was developed to determine the absorbed dose to the bone marrow, and the dose-limiting organ was the kidney in 197 of 200 patients.
Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System
- D. Hsu, Ezgi Ilan, W. Peterson, J. Uribe, M. Lubberink, C. Levin
- Physics, MedicineThe Journal of Nuclear Medicine
- 27 April 2017
Excellent performance was achieved with the Discovery MI, including 375 ps FWHM coincidence time resolution and sensitivity of 14 cps/kBq, and comparisons between reconstruction algorithms and other multimodal silicon photomultiplier and non–silicon photomULTiplier PET detector system designs indicated that performance can be substantially enhanced with this next-generation system.
Blood-brain barrier p-glycoprotein function in Alzheimer's disease
Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.
Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
- M. Sandström, I. Velikyan, M. Lubberink
- Medicine, BiologyThe Journal of Nuclear Medicine
- 1 October 2013
There is no preference for either tracer for PET/CT evaluation of somatostatin receptor–expressing tumors from a radiation dosimetry point of view, and the effective dose for a typical 100-MBq administration of 68Ga-DOTATATE and 68 Ga-DotATOC is 2.1 mSv for both tracers.
Evaluation of Tracer Kinetic Models for Quantification of P-Glycoprotein Function using (R)-[11C]Verapamil and PET
- M. Lubberink, G. Luurtsema, A. Lammertsma
- Biology, MedicineJournal of cerebral blood flow and metabolism…
- 1 February 2007
The aim of the present study was to evaluate the kinetics of pure (R)-[11C]verapamil in humans and to develop a tracer kinetic model for the analysis of P-gp-mediated transport of (R), including the putative contribution of its radioactive metabolites.
Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE
Evaluating the dose–response relationship for pancreatic neuroendocrine tumors treated with PRRT using 177Lu-DOTATATE implies a significant correlation between absorbed dose and tumor reduction.
Pharmacokinetics and red cell utilization of 52Fe/59Fe‐labelled iron polymaltose in anaemic patients using positron emission tomography
High red cell utilization of iron polymaltose occurred in anaemic patients and the reticuloendothelial uptake of this complex may reflect the safety of polysaccharide complexes.
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
- Charlotte S. van der Vos, D. Koopman, E. Visser
- MedicineEuropean Journal of Nuclear Medicine and…
- 8 July 2017
New developments in positron emission tomography/computed tomography (PET/CT) include time-of-flight (TOF), point-spread-function (PSF), maximum-a-posteriori (MAP) based reconstruction, smaller voxels, respiratory gating, metal artefact reduction, and administration of quadratic weight-dependent 18F–fluorodeoxyglucose (FDG) activity are described.
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
- K. Chiotis, L. Saint‐Aubert, A. Nordberg
- Biology, PsychologyEuropean Journal of Nuclear Medicine and…
- 21 March 2016
The tau-specific PET tracer [18F]THK5317 images in vivo show the expected regional distribution of tau pathology, which contrasts with the different patterns of hypometabolism and amyloid-beta deposition.